| Serial Number | 79213596 |
| Word Mark | ARDENA |
| Filing Date | Wednesday, March 8, 2017 |
| Status | 706 - SECTION 71 ACCEPTED |
| Status Date | Monday, July 29, 2024 |
| Registration Number | 5357360 |
| Registration Date | Tuesday, December 19, 2017 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 3, 2017 |
| Goods and Services | Legal consultation and advice; reviewing standards and practices to assure compliance with pharmaceutical laws and regulations |
| Goods and Services | Pharmaceutical research and pharmaceutical development; inspection of pharmaceutical products; research on pharmaceutical products; testing of pharmaceutical products; scientific investigations of pharmaceutical products for medical purposes; pharmaceutical development of drugs; development of pharmaceutical products; medical and pharmaceutical research services; consultancy pertaining to pharmacology; qualitative evaluation of pharmaceuticals; research relating to pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research regarding pharmaceutical products; research in the field of pharmacogenetics; scientific research in the field of pharmaceutics; testing of the effectiveness of pharmaceutical products; research and development services in the field of biology, gynecology, biotechnology, for others in the pharmaceutical industry; conducting clinical trials for others in the field of pharmaceutical products; research and development in the pharmaceutical field and biotechnology; consultancy relating to research and development in the pharmaceutical field; providing scientific research information in the field of clinical trials of pharmaceuticals; conducting early evaluations in the field of new pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research; [ providing scientific advice in relation to carbon offsetting; ] scientific testing; research and development services; conducting scientific feasibility studies; scientific analysis, namely, chemical analysis; [ scientific and technological services, namely, design in the field of computer networking hardware, computer datacenter architecture, ] scientific and technological services, namely, scientific research, analysis, testing, in the field of pharmaceuticals; providing scientific information in the field of biology, gynecology, biotechnology; providing of scientific research information in the field of, physics, genetics, pharmaceutical, biotechnology, gynecology; scientific medical research; scientific research for medical purposes; research in the field of physics, bacteriology, gynecology, biotechnology; contract research related to molecular sciences; research relating to molecular sciences; scientific research related to chemistry and biology; providing scientific research information in the field of genetics, physics, pharmaceuticals, biotechnology, organic chemistry |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 7, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 7, 2017 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Pharmavize nv |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 32 - NOT AVAILABLE |
| Address | Mariakerke B-9030 BE |
| Party Name | Pharmavize nv |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 32 - NOT AVAILABLE |
| Address | BE |
| Party Name | Pharmavize nv |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 32 - NOT AVAILABLE |
| Address | BE |
| Event Date | Event Description |
| Thursday, August 3, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, August 7, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 7, 2017 | ASSIGNED TO EXAMINER |
| Friday, August 11, 2017 | APPLICATION FILING RECEIPT MAILED |
| Thursday, August 17, 2017 | NON-FINAL ACTION WRITTEN |
| Friday, August 18, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, August 21, 2017 | REFUSAL PROCESSED BY MPU |
| Monday, August 21, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, August 23, 2017 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, August 23, 2017 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, August 23, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 23, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 23, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 24, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, September 8, 2017 | REFUSAL PROCESSED BY IB |
| Tuesday, December 19, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, September 13, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 3, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 3, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, March 19, 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, March 27, 2018 | FINAL DISPOSITION PROCESSED |
| Tuesday, March 27, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Saturday, May 12, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, December 19, 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Tuesday, November 7, 2023 | TEAS SECTION 71 RECEIVED |
| Monday, July 29, 2024 | REGISTERED-SEC.71 ACCEPTED |
| Monday, July 29, 2024 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Sunday, July 28, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |